期刊
STEM CELL RESEARCH & THERAPY
卷 7, 期 -, 页码 -出版社
BMC
DOI: 10.1186/s13287-016-0280-9
关键词
Human mesenchymal stem cells; Recombinant adeno-associated virus; Multiple gene transfer; Transforming growth factor beta; SOX9; Chondrogenesis
资金
- National Science Foundation of China (NSFC) [81441056]
- Osteoarthritis Research Society International (OARSI Scholarship Award)
- German Osteoarthritis Foundation (Deutsche Arthrose-Hilfe e.V.)
Background: Articular cartilage has a limited potential for self-healing. Transplantation of genetically modified progenitor cells like bone marrow-derived mesenchymal stem cells (MSCs) is an attractive strategy to improve the intrinsic repair capacities of damaged articular cartilage. Methods: In this study, we examined the potential benefits of co-overexpressing the pleiotropic transformation growth factor beta (TGF-beta) with the cartilage-specific transcription factor SOX9 via gene transfer with recombinant adeno-associated virus (rAAV) vectors upon the biological activities of human MSCs (hMSCs). Freshly isolated hMSCs were transduced over time with separate rAAV vectors carrying either TGF-beta or sox9 in chondrogenically-induced aggregate cultures to evaluate the efficacy and duration of transgene expression and to monitor the effects of rAAV-mediated genetic modification upon the cellular activities (proliferation, matrix synthesis) and chondrogenic differentiation potency compared with control conditions (lacZ treatment, sequential transductions). Results: Significant, prolonged TGF-beta/sox9 co-overexpression was achieved in chondrogenically-induced hMSCs upon co-transduction via rAAV for up to 21 days, leading to enhanced proliferative, biosynthetic, and chondrogenic activities relative to control treatments, especially when co-applying the candidate vectors at the highest vector doses tested. Optimal co-administration of TGF-beta with sox9 also advantageously reduced hypertrophic differentiation of the cells in the conditions applied here. Conclusion: The present findings demonstrate the possibility of modifying MSCs by combined therapeutic gene transfer as potent future strategies for implantation in clinically relevant animal models of cartilage defects in vivo.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据